Results 101 to 110 of about 391 (114)

Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis

Expert Review of Clinical Immunology, 2023
David Burden
exaly  

Mortality in generalized pustular psoriasis: A population-based national register study

Journal of the American Academy of Dermatology, 2023
Jenny M Norlin, Sofia Löfvendahl, Marcus Schmitt-Egenolf   +2 more
exaly  

Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan

Journal of the American Academy of Dermatology, 2022
Kiyohide Fushimi, Hiroyuki Matsue, Hideo Yasunaga   +2 more
exaly  

<p>Diagnosis and screening of patients with generalized pustular psoriasis</p>

Psoriasis: Targets and Therapy, 2019
Quinn Thibodeaux, Tina Bhutani, Mary Patricia Smith   +2 more
exaly  

IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis

Journal of Allergy and Clinical Immunology, 2017
Johann Gudjonsson, Paul W Harms, Zhiqiang Yin   +2 more
exaly  

Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine

JAAD Case Reports, 2021
exaly  

Treatments of Generalized Pustular Psoriasis: A Multicenter Study in Japan

Journal of Dermatology, 1999
M Ohkido, A Ohkawara
exaly  

[Generalized pustular psoriasis].

Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 2003
R, DEGOS, G, GARNIER, J, HEWITT, J, PY
openaire   +3 more sources

Case report: Efficacy of tofacitinib in the treatment of generalized pustular psoriasis

Frontiers in Medicine
Tang Ting
exaly  

Biologics for generalized pustular psoriasis: a systematic review and single-arm meta-analysis

Frontiers in Immunology
Yan-Ping Bai
exaly